Fungus Among Us: An 8-Year Retrospective Study of Fungal Infections at a Tertiary-Care Hospital in Bucharest, Romania
Pathogens · 2025
DOI: 10.3390/pathogens14101061 ↗At a glance
Journal article in Pathogens, 2025. Written by Alina Maria Borcan and 8 co-authors. Institution: Faculty of Medicine, The University of Medicine and Pharmacy "Carol Davila", Dionisie Lupu Street, No. 37, 050474 Bucharest, Romania. Major MEDLINE topics: Mycoses, Fungi. 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: Carol Davila University of Medicine and Pharmacy, University of Medicine and Pharmacy Carol Davila.
Abstract (original language)
Despite the devastating consequences of fungal disease, research struggles to catch up to present needs. This study aims to give a broad perspective on the situation, investigating patterns and distribution of fungal pathogens and monitoring trends of resistance to antifungal drugs, over an 8-year timeframe, at the National Institute of Infectious Diseases “Prof. Dr. Matei Balș” in Bucharest, Romania. Samples were inoculated on Sabouraud or Brilliance Candida Agar media; strains were identified using MALDI-TOF MS; and antifungal sensitivity testing was performed using E-Tests strips, VITEK2 Compact and MICRONAUT-AM automatic systems. Candida albicans, accounting for 42% of the positive samples, was the most common pathogen observed, with only 17% of the isolates being susceptible to all antifungals tested, while it was also predominant and deadly in the ICU. The emerging Candidozyma auris, found in 8% of the candidoses, exhibited a fluconazole resistance rate of 96.3%. Of the Aspergillus fumigatus strains, 35.7% showed resistance to azoles, and 25% to amphotericin B. In the ICU, more than half of A. flavus-, A. fumigatus- or A. niger-related cases culminated in death. Antifungal resistance is not to be treated lightly, as it is still a complex and dynamic threat, with devastating consequences.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Faculty of Medicine, The University of Medicine and Pharmacy "Carol Davila", Dionisie Lupu Street, No. 37, 050474 Bucharest, Romania.
- The National Institute of Infectious Diseases "Prof. Dr. Matei Balș", Doctor Grozovici Street, No. 1, 021105 Bucharest, Romania.
- St. Mary Clinical Hospital, Department of General Surgery, Ion Mihalache Boulevard, No 37-39, 011172 Bucharest, Romania.
- The National Institute of Mother and Child Health "Alessandrescu-Rusescu", Materno-Fetal Medicine Excellence Center, Lacul Tei Boulevard, No 120, 20382 Bucharest, Romania.
ORCID profiles: Mihaela-Cristina Olariu, Bianca Secuiu, Dragos Cretoiu, Laura Georgiana Caravia
Funding
- Carol Davila University of Medicine and Pharmacy
- University of Medicine and Pharmacy Carol Davila
Cite
APA
Borcan, A. M., Olariu, M. C., Anghel, T. G., Rotaru, E., Secuiu, B., Simoiu, M., Copca, N., Cretoiu, D., & Caravia, L. G. (2025). Fungus Among Us: An 8-Year Retrospective Study of Fungal Infections at a Tertiary-Care Hospital in Bucharest, Romania. Pathogens. https://doi.org/10.3390/pathogens14101061
Vancouver
Borcan AM, Olariu MC, Anghel TG, Rotaru E, Secuiu B, Simoiu M, et al. Fungus Among Us: An 8-Year Retrospective Study of Fungal Infections at a Tertiary-Care Hospital in Bucharest, Romania. Pathogens. 2025. doi:10.3390/pathogens14101061
BibTeX
@article{Borcan2025,
author = {Borcan, Alina Maria and Olariu, Mihaela-Cristina and Anghel, Teodora Gabriela and Rotaru, Elena and Secuiu, Bianca and Simoiu, Madalina and Copca, Narcis and Cretoiu, Dragos and Caravia, Laura Georgiana},
title = {Fungus Among Us: An 8-Year Retrospective Study of Fungal Infections at a Tertiary-Care Hospital in Bucharest, Romania},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14101061}
}
EUVIMED